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Thank you for providing the information about your studies on the relationship between ventricular ectopic beat frequency and heart rate. The results of our baseline studies are clearly in agreement since a majority of patients have a strongly positive correlation between heart rate and PVC frequency. The method you have used to display this correlation is an interesting one and if my interpretation is correct, would demonstrate this relationship only when it is a positive one. I am uncertain as to how some of our patients with complex relationships between PVC frequency and heart rate would be depicted using your data display format. It is interesting that you found a dissociation of this heart rate PVC frequency relationship during timolol therapy. We have not studied this matter fornally so I cannot comment directly upon your results. I do think, however, that it confirms our impression that using assessments of these relationships may be a new and interesting way to evaluate antiarrhythmic drugs. Given the large number of individual differences in this relationship, I wonder about the advisability of lumping all patients together and presenting averages for the group. I would prefer to have seen individual plots for each of your patients. I think that given the wide range of variation from patient to patient, this is the only reasonable way to examine pharmacologic effects of drugs on the relationship between heart rate and PVC frequency. years. This experience is divided into long-term survival of a group of patients with Q wave myocardial infarction (76%) and an overall group of coronary bypass patients, presumably without infarction (90%). Having reviewed our own data on perioperative myocardial infarction (PMI) and having found no difference in long-term outcome,2 we feel obliged to comment on Dr. Namay's report. First, the patients in this study were taken from the Seattle Heart Watch in which five collaborating Seattle institutions report angiographic findings.3 It is not clear that the bypass surgery was also performed in these five institutions. Because the patients in this study were operated during the early, formative years of coronary bypass (1969) (1970) (1971) (1972) (1973) (1974) , differences in patient selection, surgical techniques, vein graft preparation, and postoperative management may be important; but these differences have not been considered in the context of institutional variation. Similarly, institutional differences in operative mortality, incidence of PMI, completeness of revascularization, and long-tern bypass graft patency are not addressed. Thus, a single institution (with less favorable early and late survival statistics), contributing a disproportionate number of the PMI patients, could influence the overall experience in a biased fashion.
Second, further details about the diagnostic criteria used to identify PMI are pertinent but are not included. Since the diagnosis of PMI was made by the finding of "new or enlarged Q waves," without the aid of enzymatic or scintigraphic data, we must assume that posterior wall infarction was not diagnosed. Further, we are not told what proportion had anterior and what proportion inferior infarctions. How many had "new" and how many had "enlarged" Q waves? How were the patients with preoperative or postoperative left bundle branch block categorized? Finally, were those with PMI recognized clinically as having a significant cardiac event at the time of its occurrence (low cardiac output, need for intraaortic balloon counterpulsation, pharmacologic support, arrhythmias)? Depending on these considerations, the authors' diagnostic criteria may have excluded a cohort of patients with particularly large amounts of infarcted myocardium and expected poor longterm outcome in group 1, or inclusion of a cohort with smaller infarcts and better prognosis in group 2.
Although the operative mortality with PMI is noted to be twice that of the remaining patients (10% vs 5%), the authors did not find this difference significant. Of the overall mortality in the non-MI group, 50% (five of 10) was attributable to the surgical procedure, and 42% (10 of 24) of all deaths in the PMI group were similarly attributable. But what was the mechanism of these deaths attributed to the surgical procedure? In this context it would be important to know more precisely the causes of all early death, i.e., the absolute instance of PMI as opposed to "other" causes of death?
Likewise, since the causes of late death, cardiac vs noncardiac, are not given, we cannot determine if the excess mortality of the group with PMI is due to or merely coincidental with the occurrence of this complication. Lacking this information, futher data about the relative incidences of late postoperative congestive heart failure, angina and arrhythmias in the survivors would be of some help. The case for a direct relationship between PMI and impaired survival could be more convincingly made if data were presented to show that these patients did or did not suffer from a higher incidence of significant late events, such as bypass graft closure and late myocardial infarction. For instance, with only 2.1 grafts per patient and the majority of patients with two-or three-vessel disease, the degree to which complete revascularization was achieved is in question; and this fact alone may have significantly affected the results reported.
For these reasons, we question whether the data, as reported, support the conclusion that excessive late mortality is the direct result of PMI.
